Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone involved in glucose metabolism. As a GLP-1 receptor agonist, Semaglutide mimics the effects of endogenous GLP-1, promoting insulin secretion and suppressing glucagon release in a glucose-dependent manner—a mechanism that helps lower blood sugar without causing hypoglycemia.